🇺🇸 Glimepiride 2 mg in United States

22 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 4 reports (18.18%)
  2. Product Quality Issue — 4 reports (18.18%)
  3. Drug Ineffective — 3 reports (13.64%)
  4. Death — 2 reports (9.09%)
  5. Nausea — 2 reports (9.09%)
  6. Pruritus — 2 reports (9.09%)
  7. Rash Erythematous — 2 reports (9.09%)
  8. Adverse Drug Reaction — 1 report (4.55%)
  9. Angioedema — 1 report (4.55%)
  10. Blood Glucose Decreased — 1 report (4.55%)

Source database →

Glimepiride 2 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Glimepiride 2 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glimepiride 2 mg in United States?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.